(Q43482184)

23 November 2017

title

Immunogenic properties of the Salmonella atypical fimbriae in BALB/c mice (English)

1 reference

23 November 2017

2

1 reference

23 November 2017

Lena Strindelius

1

1 reference

23 November 2017

Staffan Normark

series ordinal

3

1 reference

23 November 2017

Ingvar Sjöholm

series ordinal

4

1 reference

23 November 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

23 November 2017

1 reference

23 November 2017

volume

22

1 reference

23 November 2017

issue

11-12

1 reference

23 November 2017

page(s)

1448-1456

1 reference

Multiple insertions of fimbrial operons correlate with the evolution of Salmonella serovars responsible for human disease

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.012

Role of T cells, TNF alpha and IFN gamma in recall of immunity to oral challenge with virulent salmonellae in mice vaccinated with live attenuated aro- Salmonella vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.012

Biodegradable microspheres. XVIII: The adjuvant effect of polyacryl starch microparticles with conjugated human serum albumin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.012

Polyacryl starch microparticles as adjuvant in oral immunisation, inducing mucosal and systemic immune responses in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.012

Extracellular antigens from Salmonella enteritidis induce effective immune response in mice after oral vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.012

Intranasal immunization using the B subunit of the Escherichia coli heat-labile toxin fused to an epitope of the Bordetella pertussis P.69 antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.012

Group B Streptococcus capsular polysaccharide-cholera toxin B subunit conjugate vaccines prepared by different methods for intranasal immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.012

Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide-cholera toxin B subunit conjugate vaccine for intranasal immunization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.012

Potent immunogenicity of the B subunits of Escherichia coli heat-labile enterotoxin: receptor binding is essential and induces differential modulation of lymphocyte subsets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.012

Characterization of polyacryl starch microparticles as carriers for proteins and drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.012

Biodegradable microspheres. IV: Factors affecting the distribution and degradation of polyacryl starch microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.012

Role of fimbriae as antigens and intestinal colonization factors of Salmonella serovars

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.012

Fimbriae- and flagella-mediated association with and invasion of cultured epithelial cells by Salmonella enteritidis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.012

A role for Salmonella fimbriae in intraperitoneal infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.012

Immunization of rabbits with enterotoxigenic E. coli colonization factor antigen (CFA/I) encapsulated in biodegradable microspheres of poly (lactide-co-glycolide).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.012

Preclinical evaluation of microencapsulated CFA/II oral vaccine against enterotoxigenic E. coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.012

Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.012

Mucosal immunization against hepatitis B virus by intranasal co-administration of recombinant hepatitis B surface antigen and recombinant cholera toxin B subunit as an adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.012

Biodegradable microspheres. V: Stimulation of macrophages with microparticles made of various polysaccharides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.012

Genomic structure, promoter sequence, and induction of expression of the mouse Nramp1 gene in macrophages.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.012

Induction of immune responses in pigs following oral administration of purified F4 fimbriae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.012

Clonal nature of Salmonella typhi and its genetic relatedness to other salmonellae as shown by multilocus enzyme electrophoresis, and proposal of Salmonella bongori comb. nov

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.012

inferred from DOI database lookup

7 January 2021

based on heuristic

The Dr hemagglutinin, afimbrial adhesins AFA-I and AFA-III, and F1845 fimbriae of uropathogenic and diarrhea-associated Escherichia coli belong to a family of hemagglutinins with Dr receptor recognition

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Oral immunization with a Salmonella typhimurium vaccine vector expressing recombinant enterotoxigenic Escherichia coli K99 fimbriae elicits elevated antibody titers for protective immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2003.10.012

1 reference

23 November 2017

1 reference